ACTA MEDICA MEDITERRANEA, vol.31, no.6, pp.1271-1276, 2015 (SCI-Expanded)
Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).